These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab. Kataoka H; Kodama F; Tomita T; Kondo M; Nagasaka A; Nishikawa S; Mukai M Intern Med; 2021 Feb; 60(4):639-643. PubMed ID: 33390490 [TBL] [Abstract][Full Text] [Related]
28. COVID-19 vaccination unveiling subclinical Sjögren's syndrome. Ramos-Casals M; Sainz-de-la-Maza M; Muxí A Clin Exp Rheumatol; 2021; 39 Suppl 133(6):228-229. PubMed ID: 34524079 [No Abstract] [Full Text] [Related]
29. Phenotypic switch from non-active primary Sjögren's syndrome to severe systemic Lupus erythematosus after COVID-19 infection in an elderly man. Roger G; Pavot A; Bonnet I; Ferlicot S; Mariette X Joint Bone Spine; 2021 Dec; 88(6):105228. PubMed ID: 34051388 [No Abstract] [Full Text] [Related]
32. Timing of national lockdown and mortality in COVID-19: The Italian experience. Silverio A; Di Maio M; Ciccarelli M; Carrizzo A; Vecchione C; Galasso G Int J Infect Dis; 2020 Nov; 100():193-195. PubMed ID: 32898670 [TBL] [Abstract][Full Text] [Related]
33. Resilience in women with primary Sjögren's syndrome. Priori R; Giardina F; Izzo R; Gattamelata A; Fusconi M; Colafrancesco S; Curcio G Rheumatol Int; 2021 Nov; 41(11):1987-1994. PubMed ID: 34091740 [TBL] [Abstract][Full Text] [Related]
34. Adolescent Sjogren's syndrome presenting as psychosis: a case series. Hammett EK; Fernandez-Carbonell C; Crayne C; Boneparth A; Cron RQ; Radhakrishna SM Pediatr Rheumatol Online J; 2020 Feb; 18(1):15. PubMed ID: 32046763 [TBL] [Abstract][Full Text] [Related]
35. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial. Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310 [TBL] [Abstract][Full Text] [Related]
36. Effects of the COVID-19 Emergency and National Lockdown on Italian Citizens' Economic Concerns, Government Trust, and Health Engagement: Evidence From a Two-Wave Panel Study. Graffigna G; Palamenghi L; Savarese M; Castellini G; Barello S Milbank Q; 2021 Jun; 99(2):369-392. PubMed ID: 33822424 [TBL] [Abstract][Full Text] [Related]
37. Fibromyalgia features in patients with primary Sjögren's syndrome. Evidence of a relationship with psychological depression. Vitali C; Tavoni A; Neri R; Castrogiovanni P; Pasero G; Bombardieri S Scand J Rheumatol; 1989; 18(1):21-7. PubMed ID: 2704982 [TBL] [Abstract][Full Text] [Related]
38. Chronic Pruritus in Primary Sjögren's Syndrome: Characteristics and Effect on Quality of Life. Valdes-Rodriguez R; Rowe B; Lee HG; Moldovan T; Chan YH; Blum M; Yosipovitch G Acta Derm Venereol; 2017 Mar; 97(3):385-386. PubMed ID: 27563704 [No Abstract] [Full Text] [Related]
39. [Cognition disorders and associated behaviors associated with Gougerot-Sjögren syndrome]. Blanc F; Fleury M; Korganow AS; Crémel N; de Seze J; Sellal F; Tranchant C Rev Neurol (Paris); 2009 Dec; 165 Spec No 4():F267-72. PubMed ID: 20402006 [No Abstract] [Full Text] [Related]
40. Sjögren syndrome: reduced quality of life as an oral-systemic consequence. Iacopino AM J Can Dent Assoc; 2010; 76():a98. PubMed ID: 20719102 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]